We examined the effects of the alpha(2)-adrenoceptor (alpha(2)-AR) agonist
clonidine on pressure-flow relationships in the upper airway. Inspired and
expired airflows, subglottic tracheal pressure (PTR), mask pressure and mid
dle pharyngeal constrictor (MPC) and diaphragm electromyogram (EMG) activit
ies were recorded in awake standing goats. Clonidine-induced central apneas
were always associated with continuous tonic activation of the MPC. Subglo
ttic PTR during expiration increased progressively in a dose-dependent mann
er after clonidine administration. In all cases, positive subglottic PTR wa
s maintained throughout the duration of clonidine-induced apneas and was su
fficient to retard or prevent expiratory flow during early and mid-expirati
on indicating complete airway closure. The effects of clonidine were revers
ed by selective alpha(2)-AR blockade with SKF-86466. Central apneas after s
pontaneous augmented breaths (sighs) were associated with continuous tonic
activation of the MPC throughout the duration of the prolonged TE intervals
. However, subglottic PTR during expiration was not significantly different
from control breaths and there was no evidence of increased expiratory air
way resistance or delayed expiratory flow. We conclude that continuous toni
c activation of pharyngeal adductor muscles appears to be a constant featur
e of central apnea in the awake goat independent of the initiating cause of
the apnea. However, our data suggest that MPC activation alone may not be
sufficient to cause complete closure of the upper airway during central apn
ea. (C) 2000 Elsevier Science B.V. All rights reserved.